Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;57(6):996-1007.
doi: 10.1007/s11239-024-03000-2. Epub 2024 May 18.

Optimizing resource allocation: Cost-effectiveness of specified D-dimer cut-offs in cancer patients with suspected venous thromboembolism

Affiliations

Optimizing resource allocation: Cost-effectiveness of specified D-dimer cut-offs in cancer patients with suspected venous thromboembolism

Teodora Biciusca et al. J Thromb Thrombolysis. 2024 Aug.

Abstract

An accurate diagnosis of venous thromboembolism (VTE) is crucial, given the potential for high mortality in undetected cases. Strategic D-dimer testing may aid in identifying low-risk patients, preventing overdiagnosis and reducing imaging costs. We conducted a retrospective, comparative analysis to assess the potential cost savings that could be achieved by adopting different approaches to determine the most effective D-dimer cut-off value in cancer patients with suspected VTE, compared to the commonly used rule-out cut-off level of 0.5 mg/L. The study included 526 patients (median age 65, IQR 55-75) with a confirmed cancer diagnosis who underwent D-dimer testing. Among these patients, the VTE prevalence was 29% (n = 152). Each diagnostic strategy's sensitivity, specificity, negative likelihood ratio (NLR), as well as positive likelihood ratio (PLR), and the proportion of patients exhibiting a negative D-dimer test result, were calculated. The diagnostic strategy that demonstrated the best balance between specificity, sensitivity, NLR, and PLR, utilized an inverse age-specific cut-off level for D-dimer [0.5 + (66-age) × 0.01 mg/L]. This method yielded a PLR of 2.9 at a very low NLR for the exclusion of VTE. We observed a significant cost reduction of 4.6% and 1.0% for PE and DVT, respectively. The utilization of an age-adjusted cut-off [patient's age × 0.01 mg/L] resulted in the highest cost savings, reaching 8.1% for PE and 3.4% for DVT. Using specified D-dimer cut-offs in the diagnosis of VTE could improve economics, considering the limited occurrence of confirmed cases among patients with suspected VTE.

Keywords: Cancer; Cost-effectiveness analysis; D-dimer; Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diagnostic algorithm for suspected DVT (first event) using compression ultrasonography, adapted according to current guidelines [1]. Pricings for CUS and D-dimer testing were taken from the German scale of fees for physicians (MFS) 51. Abbreviations: CUS, compression ultrasound; DVT, deep vein thrombosis; MFS, Medical fee schedule
Fig. 2
Fig. 2
Diagnostic algorithm for suspected PE in hemodynamically stable patients, adapted according to current guidelines [1]. All prices were taken from the German scale of fees for physicians (MFS) 51. Abbreviations: CUS, compression ultrasound; CTPA, computed tomography pulmonary angiography; DVT, deep vein thrombosis; EchoCG, echocardiogram; MFS, Medical fee schedule; PE, pulmonary embolism; RH, right heart; sPESI, simplified Pulmonary Embolism Severity Index; VTE, venous thromboembolism; V/Q-scintigraphy, ventilation-perfusion scintigraphy

Similar articles

References

    1. Federführende Fachgesellschaft: Deutsche Gesellschaft für Angiologie – Gesellschaft für Gefäßmedizin. AWMF-S2k-Leitlinie: Diagnostik und Therapie der Venenthrombose und Lungenembolie. https://register.awmf.org/assets/guidelines/065-002l_S2k_Venenthrombose-... (awmf.org). Accessed 10 Apr 2024
    1. Wendelboe AM, Raskob GE (2016) Global Burden of Thrombosis. Circ Res 118(9):1340–1347. 10.1161/CIRCRESAHA.115.306841 10.1161/CIRCRESAHA.115.306841 - DOI - PubMed
    1. Raskob GE, Angchaisuksiri P, Blanco AN et al (2014) Thrombosis. Arterioscler Thromb Vasc Biol 34(11):2363–2371. 10.1161/ATVBAHA.114.304488 10.1161/ATVBAHA.114.304488 - DOI - PubMed
    1. Virani SS, Alonso A, Benjamin EJ et al (2020) Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation. 141(9). 10.1161/CIR.0000000000000757 - PubMed
    1. Schellong SM (2011) Therapie der Beinvenenthrombose und der Lungenembolie. Internist (Berl) 52(11):1284–1291. 10.1007/s00108-011-2868-6 10.1007/s00108-011-2868-6 - DOI - PubMed

Substances

LinkOut - more resources